VEDOLIZUMAB vs VEMURAFENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VEDOLIZUMAB vs VEMURAFENIB: Safety Overview
| Metric | VEDOLIZUMAB | VEMURAFENIB |
|---|---|---|
| Total FAERS Reports | 73,857 | 8,562 |
| Deaths Reported | 3,476 | 1,040 |
| Death Rate | 4.7% | 12.1% |
| Hospitalizations | 21,677 | 2,368 |
| Average Patient Age | 50.0 yrs | 58.1 yrs |
| % Female Patients | 56.5% | 45.7% |
| FDA Approval Date | N/A | Aug 17, 2011 |
| Manufacturer | Takeda Pharmaceuticals America, Inc. | Genentech, Inc. |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Prescription |